Статины при хронической болезни почек. Существует ли препарат выбора?
ОМ Драпкина, ОН Корнеева - Кардиоваскулярная терапия и …, 2015 - cyberleninka.ru
Хроническая болезнь почек (ХБП) ассоциирована с повышенным сердечно-
сосудистым риском, и требует тщательного контроля дислипидемии. Терапия …
сосудистым риском, и требует тщательного контроля дислипидемии. Терапия …
Effects of statin therapy on chronic kidney disease patients with coronary artery disease
H Shen, X Chen, J Lu, H Yang, Y Xu, A Zhu… - Lipids in Health and …, 2018 - Springer
Background Long-term persistence of statin therapy provided an ongoing reduction in
mortality among patients with and without a known history of CVD, and renoprotective effect …
mortality among patients with and without a known history of CVD, and renoprotective effect …
Effects of atorvastatin dose and concomitant use of angiotensin-converting enzyme inhibitors on renal function changes over time in patients with stable coronary …
E Wieczorek-Surdacka, J Świerszcz… - International Journal of …, 2016 - mdpi.com
Angiotensin-converting enzyme inhibitors (ACEI) and statins are widely used in patients with
coronary artery disease (CAD). Our aim was to compare changes in glomerular filtration rate …
coronary artery disease (CAD). Our aim was to compare changes in glomerular filtration rate …
Renal dysfunction following elective endovascular aortic aneurysm repair
D Radak, M Neskovic, P Otasevic… - Current Vascular …, 2019 - ingentaconnect.com
Abdominal aortic aneurysm (AAA) is a degenerative disease of the aortic wall with
potentially fatal complications. Open repair (OR) was considered the gold standard, until the …
potentially fatal complications. Open repair (OR) was considered the gold standard, until the …
[HTML][HTML] Statins: practical considerations–a review
K Abdullah, A Rohatgi - European Cardiology Review, 2014 - ncbi.nlm.nih.gov
Statins are currently the most efficacious and widely prescribed lipid-lowering medications.
The 2013 ACC/AHA cholesterol guidelines provide a dramatic shift in treatment approach …
The 2013 ACC/AHA cholesterol guidelines provide a dramatic shift in treatment approach …
[PDF][PDF] Rosuvastatin ameliorates inflammation, renal fat accumulation, and kidney injury in transgenic spontaneously hypertensive rats expressing human C-reactive …
J Šilhavý, V Zídek, V Landa, M Šimáková… - Physiological …, 2015 - biomed.cas.cz
Recently, we derived “humanized” spontaneously hypertensive rats (SHR-CRP) in which
transgenic expression of human CRP induces inflammation, oxidative stress, several …
transgenic expression of human CRP induces inflammation, oxidative stress, several …
Non-invasive imaging for evaluating cardiovascular involvement in patients with primary and lupus nephritis
M Atteritano, L Visconti, G Dattilo… - The Open …, 2019 - benthamopen.com
Background: Evidence suggests that proteinuric diseases, such as primary or secondary
glomerulonephritis, increase cardiovascular risk, but few studies confirmed this association …
glomerulonephritis, increase cardiovascular risk, but few studies confirmed this association …
Association of glomerular filtration rate with slow coronary flow in patients with normal to mildly impaired renal function
F Akin, O Celik, B Ayça, AA Yalçın, I Altun… - Angiology, 2014 - journals.sagepub.com
We evaluated the association between estimated glomerular filtration rate (eGFR) and slow
coronary flow (SCF) in patients with normal to mildly impaired renal function; 211 patients …
coronary flow (SCF) in patients with normal to mildly impaired renal function; 211 patients …
Editorial (thematic issue: sex, environment, physical activity, diet, and obesity in cardiovascular disease risk)
D Mukherjee, TF Whayne - Current Vascular Pharmacology, 2016 - ingentaconnect.com
Modification of cardiovascular (CV) disease risk and how best to achieve this goal have
become major hot topics in the prevention of CV disease. Key components in this discussion …
become major hot topics in the prevention of CV disease. Key components in this discussion …